Effect of molecular hydrogen treatment on Sepsis-Associated encephalopathy in mice based on gut microbiota

Beibei Dong, Chunjing Zhou, Hongguang Chen, Ning Luo, Qingqing Han, Yingning Li, Yongbao Yu, Yuanyuan Bai

Read more:

DOI: 10.1111/cns.14043 DOI is the universal ID for this study.

This link will take you to the full study.


Introduction: In our experiments, male wild-type mice were randomly divided into four groups: the sham, SAE, SAE + 2% hydrogen gas inhalation (H2 ), and SAE + hydrogen-rich water (HW) groups. The feces of the mice were collected for 16 S rDNA analysis 24 h after the models were established, and the serum and brain tissue of the mice were collected for nontargeted metabolomics analysis. Aim: Destruction of the intestinal microbiota is a risk factor for sepsis and subsequent organ dysfunction, and up to 70% of severely ill patients with sepsis exhibit varying degrees of sepsis-associated encephalopathy (SAE). The pathogenesis of SAE remains unclear. We aimed to explore the changes in gut microbiota in SAE and the regulatory mechanism of molecular hydrogen.

Results: Molecular hydrogen treatment significantly improved the functional outcome of SAE and downregulated inflammatory reactions in both the brain and the gut. In addition, molecular hydrogen treatment improved gut microbiota dysbiosis and partially amended metabolic disorder after SAE. Conclusions: Molecular hydrogen treatment promotes functional outcomes after SAE in mice, which may be attributable to increasing beneficial bacteria, repressing harmful bacteria, and metabolic disorder, and reducing inflammation. Keywords: gut microbiota; hydrogen gas (H2); hydrogen-rich water (HW); molecular hydrogen treatment; sepsis-associated encephalopathy (SAE).

Publish Year 2022
Country China
Rank Positive
Journal CNS Neuroscience & Therapeutics
Primary Topic Brain
Secondary TopicGut Microbiome
Model Mouse
Tertiary TopicSepsis
Vehicle Water (Dissolved)
pH Neutral
Application Ingestion